Clinical Trials · NCT07339423
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 1,150
- Start date
- Feb 2026
- Locations
- 72 sites, 9 countries
- Primary endpoint
- Relative change in body weight